@shaneparrish: The future of healthcare is proactive. I went to the one in London and the whole experience blew me away. Hjalmar and D…
Summary
Neko has raised a $700M Series C to advance proactive healthcare across multiple regulatory environments, as announced by co-founder Hjalmar Nilsonne.
View Cached Full Text
Cached at: 07/15/26, 11:51 AM
The future of healthcare is proactive.
I went to the one in London and the whole experience blew me away.
Hjalmar and Daniel are tackling a hard problem (proactive healthcare at scale across multiple regulatory environments) to the benefit of all.
Highly recommend you give it a try.
Hjalmar Nilsonne (@HNilsonne): Today we’re announcing that @Neko has raised a $700M Series C.
@eldsjal and I started the company with the belief that the solution to the trickiest problems in healthcare won’t come from scaling the existing system.
Medicine has spent centuries getting good at treating
Similar Articles
@tferriss: I’ve been waiting a long time for the right health-tech innovation, and @Neko Health is where I’m placing my biggest be…
Tim Ferriss endorses Neko Health's high-definition body scan service, which has raised $700M in Series C funding and is expanding to the US after serving over 100,000 people in the UK and Sweden.
@shaneparrish: Future of healthcare is wild.
Neko Health has upgraded its scans to provide body composition data, including visceral fat measurement.
Spotify’s Daniel Ek is bringing his body-scanning clinics to the US
Spotify founder Daniel Ek's preventive health startup Neko Health plans to expand into the US with a New York clinic after a $700 million funding round, using AI-powered full-body scans to detect diseases early.
@ycombinator: Congrats to @angle_health (YC W20) on their $200M Series C at a $2.7B valuation! They're an AI-native health benefits p…
Angle Health, a Y Combinator-backed AI-native health benefits platform for small businesses, has raised $200 million in Series C funding at a $2.7 billion valuation, demonstrating significant growth and profitability in the regulated health insurance sector.
@fidjissimo: Very excited to work with @morgancheatham @jimihendrixlive on this; they were one of the first investors to bet on the …
Morgan Cheatham and B Capital investors announce a partnership backing Chronicle Bio AI, a startup building a new AI model to understand and treat complex chronic diseases hidden biological heterogeneity.